No Data
No Data
10-Q: Quarterly report
Bowen Acquisition Corp Announces Merger Details in Press Release
Health products company “Qianzhi Biotechnology” plans to go public in the US under the cover of SPAC
Qianzhi Group Holding (Cayman) Limited, the holding company of Shenzhen Qianzhi Biotechnology Co., Ltd., Shenzhen Qianzhi Biotechnology Co., Ltd. from Shenzhen, Guangdong, signed a merger agreement with SPAC (US special purpose acquisition company) Bowen Acquisition Corp (BOWN) to be listed on the US NASDAQ through a backshell SPAC.
Bowen Acquisition Agrees to Merge With Shenzhen Qianzhi BioTechnology
Bowen Acquisition (BOWN) said late Thursday it signed an agreement to merge with Shenzhen Qianzhi BioTechnology, a biotech firm in China. Under the terms, Bowen's wholly owned unit, Bowen Merger Sub,
Trading Halt: Halt Status Updated at 6:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 6:55:00 AM ET: Quotation Resumption: News and Resumption Times
Bowen Acquisition Enters Into Merger Agreement With Shenzhen Qianzhi Biotech Company
Pursuant to the Merger Agreement, BOWN's wholly owned subsidiary, Bowen Merger Sub, a Cayman Islands exempted company, will merge (the "Merger" or the "Business Combination") with and into Qianzhi Gro
No Data